Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach

Table 1 Patient characteristics

Patient no.	Age [years]	BMI [kg/m²]	Age at BMD diagnosis [years]	Family history for BMD	Skeletal muscle biopsy	Genetic study	Myopathic EMG	Established heart disease	Current medication
1	49	31	45	-	+	+	+	+	ACE-I + β-BA + Diur.
2	56	29	25	-	+	n/a	+	+	β-BA + Diur.
3	42	22	15	-	+	-	+	+	ACE-I + Diur.
4	51	23	1	-	+	-	+	+	-
5	26	22	4	-	+	-	+	-	-
6	23	24	1	-	+	+	+	+	-
7	37	24	6	-	+	-	+	-	-
8	35	23	10	-	+	+	+	+	ACE-I
9	26	19	6	-	+	n/a	+	-	-
10	43	23	20	-	-	+	+	-	-
11	11	23	2	-	+	n/a	+	-	-
12	41	25	1	+	+	+	+	-	-
13	14	19	0.5	-	+	+	+	-	-
14	12	14	6	-	n/a	+	+	-	-
15	55	23	33	+	+	+	+	+	-

BMI = body mass index; EMG = electromyogram; ACE-I = angiotensin-converting-enzyme inhibitor; β-BA = beta-blocking agent; Diur. = diuretic; n/a = not applied.

ISSN: 1532-429X